PG

Parul Gupta

Active Director Director DIN 10211288
DIN 10211288 First appointment Jun 2023 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2023
Shareholding value •••• Premium profile

About Parul Gupta

Data last updated:

Parul Gupta is a Director at Gastomach Pharmaceuticals Private Limited (since 2023). The company operates in Trading. Gastomach Pharmaceuticals Private Limited reported revenue of ₹35.6 Lakh (FY 2025).

DIN 10211288
Primary Designation Director
Industry Trading
First Appointment 23 Jun 2023
Oldest Company Age 6 yrs
Largest company Gastomach Pharmaceuticals Private Limited · ₹35.6 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director23 Jun 20232020₹35.6 Lakh (FY 2025)Active

Directorship timeline

Open interactive timeline →
Gastomach Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Parul Gupta

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Parul Gupta

Parul Gupta currently holds 1 directorship: Gastomach Pharmaceuticals Private Limited (Director, since 23 Jun 2023, revenue ₹35.6 Lakh (FY 2025)).

Parul Gupta was first appointed on 23 Jun 2023 as Director at Gastomach Pharmaceuticals Private Limited.

The current boards of Parul Gupta's companies include Rahul Singhal (Gastomach Pharmaceuticals Private Limited), Sajal Singhal (Gastomach Pharmaceuticals Private Limited), Vishal Gupta (Gastomach Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available